Molecule News and Research

RSS

Study provides a specific target to tackle breast cancer relapse

Molecular targets for therapies that could prevent breast cancer recurrence have been identified by a group of German, Norwegian and British scientists who analyzed tumour cells that proved resistant to the original treatment.

25 Oct 2021

Are non-human primates at risk of SARS-CoV-2 exposure through wastewater contact?

Researchers have been investigating the potential for SARS-CoV-2 to spread to NHP through wastewater.

25 Oct 2021

Molecular features of SARS-CoV-2 variant receptor binding

Researchers have been investigating the changes in receptor binding in these variants that increase the danger they pose.

25 Oct 2021

Study finds FDA-approved drug has potent antiviral activity against SARS-CoV-2 and variants of concern

A new study aimed to examine the antiviral potential of atovaquone against the original SARS-CoV-2 strain and other variants of concern.

25 Oct 2021

Molecular mechanism that controls the transition from acute to chronic pain revealed

A new study led by University of California, Irvine researchers is the first to reveal the specific molecular mechanism that controls the transition from acute to chronic pain, and identifies this mechanism as a critical target for disease-modifying medicines.

25 Oct 2021

Study findings may lead to new treatments to fight deadly C. difficile infections

A University of California, Irvine-led study suggests that the glucosyltransferase domain (GTD) is an ideal molecular target for therapeutic interventions for Clostridioides difficile infection (CDI). These findings may lead to new treatments to fight this deadly disease.

22 Oct 2021

Researchers identify mechanism behind insufficient treatment efficacy of psoriasis drugs

Interleukin-12 - a messenger molecule of immune cells - was long considered to trigger the development of psoriasis.

22 Oct 2021

Improper Z-RNA recognition contributes to pathogenesis of Aicardi-Goutières syndrome

Like DNA, RNA molecules contain information through unique combinations of four different nucleotides. However, through a molecular process called RNA editing, chemical changes can be made to adenosine nucleotides that convert them to a nucleotide called inosine by enzymes known as adenosine deaminases (ADARs).

21 Oct 2021

U-M researchers target a protein channel in the cell’s lysosome to selectively kill cancer cells

Cancer treatments necessarily target unchecked cell growth, and selectively kill cancer cells while sparing normal cells and avoiding general toxicity in the human body.

20 Oct 2021

New discovery can pave the way to better diagnostics and therapeutics for asthma and COPD

Rutgers researchers have discovered that people with asthma and chronic obstructive pulmonary disease have a protein in their lungs that leaks a small molecule into their bloodstream that restricts their breathing instead of relaxing their airways.

20 Oct 2021

Broadly protective vaccines against coronaviruses needed to protect against future outbreaks

The coronavirus disease 2019 (COVID-19) pandemic, caused by the β-coronavirus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), alerted the world to the seriousness of the threat posed by novel viruses.

20 Oct 2021

Adding RNA-inspired ‘breaking points’ to polymer for preventing plastic pollution

Once plastic products are used and discarded, they can linger in oceans, collecting in large "garbage patches" and harming sea life. One potential solution, a biodegradable polymer called polylactide (PLA), has so far not fully lived up to its promise, showing little sign of breakdown once in seawater.

20 Oct 2021

New oligomer shows promising anti-SARS-CoV-2 properties

Scientists from the University Of New Mexico have recently identified a new cationic oligomer that may help inactivate severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

20 Oct 2021

Long-term predictions of immunity after two doses of mRNA vaccine

Researchers from York University has investigated the long-term protection of two mRNA vaccines.

20 Oct 2021

Understanding how brain cells talk could help find new treatments for neurological, psychiatric conditions

Experts from the University of Nottingham have discovered that reversing the modification of molecular messages at synapses in the human brain, may contribute to reversible mental health conditions such as anxiety, and memory diseases such as dementia.

20 Oct 2021

Lactoferrin supplements could be used as adjunct for COVID-19 and other respiratory tract infections

The antiviral properties of lactoferrin makes it a great natural supplement that could also be used as an adjunct for COVID-19 and for various other Respiratory Tract Infections (RTIs) according to a team of researchers led by the University of Huddersfield.

19 Oct 2021

Molecule News and Research

Study provides a specific target to tackle breast cancer relapse

Are non-human primates at risk of SARS-CoV-2 exposure through wastewater contact?

Molecular features of SARS-CoV-2 variant receptor binding

Study finds FDA-approved drug has potent antiviral activity against SARS-CoV-2 and variants of concern

Molecular mechanism that controls the transition from acute to chronic pain revealed

Study findings may lead to new treatments to fight deadly C. difficile infections

Researchers identify mechanism behind insufficient treatment efficacy of psoriasis drugs

Improper Z-RNA recognition contributes to pathogenesis of Aicardi-Goutières syndrome

U-M researchers target a protein channel in the cell’s lysosome to selectively kill cancer cells

New discovery can pave the way to better diagnostics and therapeutics for asthma and COPD

Broadly protective vaccines against coronaviruses needed to protect against future outbreaks

Adding RNA-inspired ‘breaking points’ to polymer for preventing plastic pollution

New oligomer shows promising anti-SARS-CoV-2 properties

Long-term predictions of immunity after two doses of mRNA vaccine

Understanding how brain cells talk could help find new treatments for neurological, psychiatric conditions

Lactoferrin supplements could be used as adjunct for COVID-19 and other respiratory tract infections

The biochemical mechanisms of remdesivir-mediated RNA synthesis inhibition

Blood pressure regulation in males and females is different, scientists say

Factors contributing to a weak antibody response to the Pfizer COVID-19 vaccine

Neuroscientists discover specific brain circuit that triggers cocaine relapse in mice

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News